often been substituted for waist circumference in the recent clinical studies. [17] [18] [19] [20] On the basis of such background, we investigated whether the presence of MS, which were classified according to NCEP-ATPIII criteria with BMI instead of waist circumference, affected the long-term outcome for patients who had CAD and underwent percutaneous coronary intervention (PCI).
Methods

Subjects and Data Collection
We analyzed 748 consecutive Japanese patients who had undergone PCI at Juntendo University Hospital from January 1984 to December 1992. In all cases, the indications for PCI were objective evidence of myocardial ischemia (positive stress test) or ischemic symptoms associated with significant angiographic stenosis. Demographic data (including age, gender, BMI), coronary risk factors (blood pressure, total cholesterol, low-density lipoproteincholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), triglyceride, fasting blood glucose, smoking history, family history of CAD), medication use at the time of PCI and data associated with procedures were prospectively gathered. Blood samples were obtained in the early morning after an overnight fast. Blood pressure was measured at the time of admission for elective cases or a few days after admission for emergency cases. Left ventricular ejection fraction (LVEF), measured by echocardiogram just after PCI during initial hospitalization, was collected in all cases. Outcome data, including death and cardiovascular (CV) events, were collected by serial contact (every 5 years) with the patients or their families until September Circ J 2006; 70: 1531 -1537 (Received May 19, 2006 ; revised manuscript received August 18, 2006; accepted September 28, 2006) Departments of Cardiology, *Cardiovascular Surgery, Juntendo University, School of Medicine, Tokyo, Japan Mailing address: Katsumi Miyauchi, MD, Department of Cardiology, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. E-mail: ktmmy@med.juntendo.ac.jp 2002. The medical records of patients who died or were treated in our hospital were examined. For patients admitted to other hospitals or clinics, the institutions were asked to provide the details of CV events and the cause of death. Mortality data was categorized according to the cause of death, such as death from all causes or cardiac death. Cardiac death included death from CAD, cardiogenic shock and sudden death. Composite cardiac events included incidence of cardiac death and non-fatal acute coronary syndrome (ACS), which included acute myocardial infarction and unstable angina pectoris. Patients were categorized according to the presence or absence of MS at baseline using the following modified criteria of NCEP-ATPIII. Obesity was defined as a BMI ≥25 kg/m 2 according to the Japanese criteria for obesity, and was used instead of waist circumference as in the NCEP-ATPIII criteria. 21 The other MS criteria were the same as those defined by NCEP-ATPIII: triglyceride ≥150 mg/dl; HDL-C <40 mg/dl for men, <50 mg/dl for women; blood pressure ≥130/85 mmHg; and fasting blood glucose ≥100 mg/dl, which is currently recommended and changed from a fasting blood glucose ≥110 mg/dl. 22 Patients who had 3 of these 5 criteria were regarded as having MS. Patients with blood pressure ≥140/90 mmHg or taking angiotensin-converting enzyme (ACE) inhibitors, calcium-channel blockers, -blockers, were regarded as having hypertension and patients with fasting blood glucose ≥126 mg/dl or under taking oral hypoglycemic agents or insulin injection, were regarded as having diabetes mellitus.
Statistical Analysis
Continuous variables are expressed as mean ± SD and were compared using the Student's t-test or the Mann-Whitney U-test. Categorical data were tabulated as frequencies and percentages, and they were compared using the chi-square test or Fisher's exact test. A Kaplan-Meier estimation with a log-rank test was used for the unadjusted analysis. Multivariate Cox proportional-hazards regression was undertaken to examine the risks for all cause deaths and cardiac events in the MS group compared with the no MS group. In addition, the risk of each 5 component of MS criteria was also estimated. The hazard ratio (HR) and 95% confidence interval (CI) of MS and its 5 components were computed using the separate models, which were adjusted for age, gender, smoker status (defined as one who smoked at the time of the PCI or had quit smoking within 1 year prior to the procedure), LDL-C, prior history of myocardial infarction, kidney failure (defined as one who was under dialysis), previous coronary artery bypass graft (CABG), presentation of ACS, LVEF, multivessel disease and procedural success (defined as a residual stenosis <50% after PCI). A p-value of <0.05 was considered significant. All data were analyzed with Dr. SPSSII for Windows (SPSS Inc, Chicago, IL, USA). 
Results
Baseline Characteristics and Prevalence of Factors Associated With MS Criteria
Baseline and clinical event data were fully documented during the follow-up period (mean follow-up, 12.0±3.6 years) for all patients. Hence, all 748 patients were enrolled. Of these, 318 patients (42.5%) had MS at the time of PCI (MS group) and 430 patients (57.5%) did not have MS (no MS group). The baseline characteristics of the 2 groups are shown in Table 1 . Patients with MS showed significantly higher BMI, fasting blood glucose, triglyceride and blood pressure, and lower HDL-C, since these characteristics are part of the definition of MS. In MS group, 78.3% of patients had hypertension and 59.4% of patients had type 2 diabetes mellitus (there were no patients with type 1 diabetes mellitus). In addition, more patients were being treated with hypoglycemic agents for diabetes and ACE inhibitors,blockers and calcium-channel blockers for hypertension in the MS group. Most patients in the 2 groups were middleaged, non-obese males who were treated with nitrates and aspirin, and had single vessel CAD with normal left ventricular contractile function. No patients in either group received stent implantations; all patients underwent PCI using only balloon angioplasty. Of the proportion of the MS components, the overall prevalence of high blood pressure was highest (66.3%), whereas obesity was the least prevalent factor (27.0%). In the MS group, although the prevalence of obesity was relatively low (49.7%), the prevalence of high blood glucose was high (62.6%) (Fig 1) .
Unadjusted and Adjusted Analysis for Mortality and CV Events
Overall, 88 patients died from all causes (including 37 patients with cardiac death), and 148 cardiac events were observed during follow-up (Table 2) . Kaplan-Meier analysis showed that the presence of MS at the time of PCI was not associated with a significant increase in mortality from all causes (log-rank test p=0.148) (Fig 2A) . However, the presence of MS at the time of PCI was significantly associated with an increased incidence of cardiac event (log-rank In the MS group, patients with a high blood pressure were the most frequently included and patients with obesity were least included. BMI, body mass index; BP, blood pressure; TG, triglyceride; FBG, fasting blood glucose; HDL, high-density lipoprotein-cholesterol. test p<0.001) ( Fig 2B) . Of each MS component, patients with high blood pressure and high fasting blood glucose revealed significantly higher mortality (log-rank test p< 0.001, p=0.043, respectively) ( Fig 3) . In contrast, patients with obesity revealed a significantly higher incidence of cardiac events (log-rank test p<0.001) (Fig 4) .
Using the Cox proportional hazard regression analysis to adjust for baseline covariates, which include age, gender, smoking history, LDL-C level, prior history of myocardial infarction, presence or absence of kidney failure, previous CABG, presentation of ACS, LVEF, multivessel disease and procedural success, MS at the time of PCI was found to be an independent and significant predictor for the incidence of cardiac events (HR 2.23, 95% CI 1.59-3.11, p<0.001), although the presence of MS at the time of PCI did not predict long-term all cause mortality (HR 1.34, 95% CI 0.88-2.05, p=0.176) ( Table 3 ). In the analysis of each component of MS, high blood pressure at the time of PCI predicted increased all cause mortality (HR 2.25, 95% CI 1.28-3.94, p=0.005) and the presence of obesity and lower HDL-C level predicted an increased incidence of cardiac events (HR 2.06, 95% CI 1.45-2.92, p<0.001 and HR 1.43, 95% CI 1.03-1.99, p=0.035, respectively) using separate models (Table 3 ).
Discussion
Based on long-term follow-up (more than 10 years) data . There was only significantly poor cumulative survival in patients with high BP (log rank test: p<0.001) and high FBG (log rank test: p=0.043) compared with those who without these conditions. BMI, body mass index; PCI, percutaneous coronary intervention. obtained from our institution, the presence of MS at the time of PCI was associated with an increased incidence of subsequent cardiac events and these risks were significant even after adjustment for baseline covariates. We focused on each component of MS, such as obesity, high blood pressure, high triglyceride level, low HDL-C level and high fasting blood glucose, and found that only patients with high blood pressure were significantly associated with increased all cause mortality. In contrast, the incidence of subsequent cardiac events was independently and significantly predicted by the presence of obesity and low HDL-C level.
Several clinical studies have demonstrated the impact of MS on mortality and the incidence of cardiac events in pa-tients without a history of previous CAD or PCI, especially among Western populations. [1] [2] [3] [4] Overall, these data showed that the presence of MS affected increased total and CV mortality. The present study differs from these studies in that all patients had a history of prior CAD and underwent PCI; no long-term follow-up data has previously been collected in such patients and in addition, only a few the previous reports were from Japan. Thus, the risk associated with the presence of MS at the time of PCI that was documented in the present study is of significant clinical importance.
While the pathogenesis of the MS and each of its components is complex and not well understood, abdominal obesity is recognized as important causative factor. [23] [24] [25] In the present study, patients with obesity, defined as BMI ≥25 kg/m 2 , have a higher risks of subsequent cardiac event than patients with any other component of MS. From this point of view, the currently proposed definitions of MS, including the IDF definition and Japanese criteria in which obesity is the necessary criterion of MS, were supposed to be appropriate, although we used BMI to classify individuals as obese because waist circumference measures were not available. In contrast, recent clinical research shows that most subjects identified as having MS based on BMI would have been simultaneously identified as abdominally obese if waist circumference cut-off points had been used. [17] [18] [19] [20] We chose a BMI ≥25 kg/m 2 as the cut-off point for obesity based on the results of a previous study in the Japanese population. 21 As a result of the present study, the prevalence of MS, though based on a different definition, was 36%, which is similar to the prevalence noted in previous studies of Western populations. 26, 27 The results of our study highlight the fact that the risk of MS may not be different among various ethnic groups, even though the definition of obesity varies according to ethnicity, as mentioned in the recent IDF definition of MS. 6 Furthermore, the results of the present study dealing with secondary prevention of CAD, which showed MS patients had an increased incidence of cardiac event, were compatible with the results of other recent studies dealing with the primary prevention of CAD. [1] [2] [3] [4] The other components of MS, such as a mildly raised blood pressure, fasting blood glucose, raised triglyceride level and reduced HDL-C, might also contribute to the increased risk. In addition, the simultaneous presence of these MS components may synergistically increase the incidence of cardiac events. The present study showed the clinical importance of the presence of MS with respect to the secondary prevention of CAD and highlighted the need to treat each MS component, even if it shows only mild impairment.
Study Limitations
In the present study, the small number of clinical events, related to the small sample size and the low risk of the patients, resulted in limited statistical power for detecting the differences in outcome. In addition, the increase in surveil-lance after PCI in both groups may have been associated with the smaller number of cardiac events. Since the present study was observational in nature, even though an adjusted analysis was performed, other unknown confounders might have affected the outcomes. There is the possibility that the differences of medication use at the time of PCI such as ACE inhibitors, -blockers, calcium-channel blockers and oral hypoglycemic agents, affected results. However, these differences would only have led to an underestimation of the association between MS and mortality or cardiac event rate. This would be probably because drugs that had established beneficial effects for the reduction of long-term mortality or cardiac event rate after PCI, such as ACE inhibitors and -blockers, were administered in more MS than no MS patients at the time of PCI. In addition, treatments given after PCI might also have affected the mortality and cardiac event rates. Thus, we reviewed changes of medication during the follow-up after PCI and found that the differences in the use of ACE inhibitors, calcium-channel blockers and oral hypoglycemic agents between the MS and no MS group at the time of PCI remained at the end of follow-up periods (data not shown). Therefore, it would appear that any effect from a change of medication was very small. Furthermore, MS patients classified in the present study included more patients with type 2 diabetes mellitus or hypertension, which are established predictors for increased mortality and cardiac event rate than the no MS patients. This strongly affected the results of the present study, therefore further investigation for the importance of MS without diabetes and hypertension was needed.
Although there were such limitations in the present study, it should be emphasized that the presence of MS at the time of PCI was associated with an increased long-term incidence of subsequent cardiac events.
Conclusions
The presence of MS at the time of PCI was associated with an increased risk of subsequent cardiac events for more than 10 years after the procedure. It was shown that the association of MS and poor outcome might be primarily Table 1 . HR and 95%CI of MS and its 5 components were computed using the separate models which were adjusted for age, gender, smoker, LDL-C, prior history of MI, kidney failure, previous CABG, presentation of ACS, LVEF, multivessel disease and PCI procedural success.
based on the obesity.
